Prognosis
Drugmaker Takeda Sees Speedy Approval of Coronavirus Treatment
This article is for subscribers only.
We’re tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Takeda Pharmaceutical Co. said its blood plasma-derived therapy against coronavirus currently in development has the potential to be among the first approved treatments for the deadly pathogen.